# Systemic inflammatory response index is associated with acute kidney injury following cardiac surgery: A retrospective cohort study using the MIMIC database

**Authors:** Huiliang Xie, Keyang Zheng, Kun Wang, Zixu Zhao, Rite Si, Jingyi Xiao, Yuzhe Yin, Xiayang Zhu, Chiara Lazzeri, Chiara Lazzeri, Chiara Lazzeri

PMC · DOI: 10.1371/journal.pone.0342780 · 2026-03-10

## TL;DR

This study found that a blood-based inflammation measure called SIRI is linked to a higher risk of kidney injury after heart surgery, suggesting it could help predict who is at risk.

## Contribution

The study demonstrates that SIRI is a novel risk marker for acute kidney injury after cardiac surgery.

## Key findings

- Higher SIRI levels were significantly associated with increased acute kidney injury risk after cardiac surgery.
- A dose-response relationship was observed between SIRI and AKI severity.
- The SIRI-AKI association was stronger in patients with a history of myocardial infarction and those not using loop diuretics.

## Abstract

This study aimed to investigate the association between the Systemic Inflammatory Response Index (SIRI) and acute kidney injury (AKI) following cardiac surgery using the Medical Information Mart for Intensive Care (MIMIC) database, and to evaluate whether SIRI could serve as a potential risk marker associated with post-cardiac surgery AKI.

We conducted a retrospective cohort study of 2,884 cardiac surgery patients from the MIMIC-IV database. SIRI was calculated as (neutrophil count × monocyte count)/ lymphocyte count. The primary outcome was AKI occurrence within seven days post-surgery. Logistic regression models and restricted cubic spline (RCS) analysis were used to assess the association between SIRI and AKI risk. Subgroup analyses were performed to evaluate potential effect modifiers.

Higher SIRI levels were significantly associated with increased AKI risk, even after adjusting for potential confounders (OR for highest vs. lowest quartile: 1.35, 95% CI: 1.04–1.77). A dose-response relationship was observed between SIRI and AKI severity (P for trend < 0.001). The association between SIRI and AKI risk was more pronounced in patients with a history of myocardial infarction (OR: 1.261, 95% CI: 1.084–1.467) and those not using loop diuretics (OR: 2.306, 95% CI: 1.200–4.434).

SIRI showed a modest but significant association with AKI following cardiac surgery. Its integration of multiple inflammatory cell types provided a comprehensive assessment of inflammatory status. The varying strength of association across different patient subgroups suggested the need for individualized risk assessment strategies. Further research is warranted to validate these findings and explore the underlying mechanisms.

## Linked entities

- **Diseases:** acute kidney injury (MONDO:0002492), myocardial infarction (MONDO:0005068)

## Full-text entities

- **Genes:** CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, IL16 (interleukin 16) [NCBI Gene 3603] {aka LCF, NIL16, PRIL16, prIL-16}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, FCGR1A (Fc gamma receptor Ia) [NCBI Gene 2209] {aka CD64, CD64A, FCG1, FCGR1, FCRI, FcgammaRI}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CD14 (CD14 molecule) [NCBI Gene 929], FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** Ischemia (MESH:D007511), respiratory failure (MESH:D012131), stroke (MESH:D020521), AKI (MESH:D058186), Cancer (MESH:D009369), ischemic (MESH:D002545), diabetes (MESH:D003920), ORCID iD (MESH:C535742), acute pancreatitis (MESH:D010195), CKD (MESH:D051436), MIMIC (MESH:C000657744), Inflammatory (MESH:D007249), shock (MESH:D012769), injury (MESH:D014947), CHD (MESH:D003327), pancreatic cancer (MESH:D010190), acute coronary syndrome (MESH:D054058), sepsis (MESH:D018805), Kidney Disease (MESH:D007674), heart failure (MESH:D006333), heart diseases (MESH:D006331), end-stage renal disease (MESH:D007676), myocardial infarction (MESH:D009203), reperfusion injury (MESH:D015427), epithelial (MESH:D009375), hypertension (MESH:D006973)
- **Chemicals:** ROS (MESH:D017382), creatinine (MESH:D003404), PONE-D-25-22563R1 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12974804/full.md

---
Source: https://tomesphere.com/paper/PMC12974804